Men s Health Concerns: Widely Experienced, Widely Misunderstood Date: March 6, 2016

Size: px
Start display at page:

Download "Men s Health Concerns: Widely Experienced, Widely Misunderstood Date: March 6, 2016"

Transcription

1 Men s Health Concerns: Widely Experienced, Widely Misunderstood Date: March 6, 2016 Sunny Linnebur, Pharm.D., BCPS, CGP Associate Professor, University of Colorado Skaggs School of Pharmacy Clinical Pharmacist University of Colorado Hospital Seniors Clinic J. Mark Ruscin, Pharm.D. FCCP, BCPS Professor and Chair, Department of Pharmacy Practice Southern Illinois University Edwardsville School of Pharmacy Learning Objectives: At the completion of this application-based activity, participants will be able to: 1. Evaluate and manage drug-induced causes of benign prostatic hyperplasia (BPH), urinary incontinence, and erectile dysfunction in adult men. 2. Compare new medications with traditional therapy options for men s health-related conditions. 3. Construct a care plan for men with benign prostatic hyperplasia, addressing concerns regarding implementing therapy, adverse events, and patient education. 4. Compare the safety, efficacy, and routes of administration of available testosterone replacement products. 5. Explain screening recommendations for prostate cancer prevention and provide appropriate education to men in the community setting. Format: Today s session will be a highly interactive discussion of the attached case studies. Based on the data available in the case study, the facilitators and audience will discuss practical management strategies and the scientific rationale that supports these strategies. Premise: You (audience members) are a pharmacist who works in an ambulatory-based setting in collaboration with a group of physicians. You have access to patient s electronic medication records. You are responsible for evaluating and monitoring the patient s therapy. You are responsible for providing comprehensive patient management and education. Page 1

2 CASE #1 Part 1 Date: Mar 2016 Initials BM DOB/Age 72 yo Sex M Race/Ethnicity Caucasian Source Patient and medical records CC/HPI (including sx analysis for CC): This having to use the bathroom at night is getting old Patient presented to his primary care physician this morning with complaints of worsening urinary symptoms. The patient has had some minor urinary symptoms in the past related to BPH, but his physician has not initiated him on medical treatment up to this point. Today, he describes symptoms of weak stream, hesitancy, and dribbling. He also states that over the past few months, it has been more common that he has to get up 2-3 times at night to urinate. Prior to that, he typically only had to get up one time, occasionally two times at night. He has not had any episodes of incontinence. He states that he has noticed the symptoms have become more problematic over the last few months. He also noticed that his night time symptoms are worse when he has coffee in the evening after dinner or if he drinks any alcohol in the evening, so he has quit drinking coffee and alcoholic beverages in the evening. His wife assists with medication taking. Patient has difficulty on occasion remembering to take his medications. Wife sets up pill box every week to help them both remember. The physician ordered routine labs, PSA, and took a urine sample for urinalysis. Past Medical History (major illnesses and surgeries) From Medical Record HTN x 25+ years Hypothyroidism x 14 years BPH s/p TIA (2011) no residual deficits Osteoarthritis of the knees 15+ years Mild cognitive impairment (MMSE Score = 26) Current Prescription/OTC Medications Start Date Drug Name/Strength/Regimen Indication 9/2014 Amlodipine 5mg daily HTN 4/2013 Losartan 50mg ½ tablet daily HTN 10/2012 Hydrochlotothiazide 12.5mg daily HTN 7/2011 Aspirin 81mg daily Stroke prevention 7/2011 Levothyroxine 0.1mg daily Hypothyroidism 2/2010 Acetaminophen 500mg 1-2 tablets BID prn Osteoarthritis Vaccinations: Influenza vaccine fall 2015; pneumococcal vaccine 2008 RX Payment: Medicare Part D ($3/$12/$45 copay) Pharmacy(ies) Used: Neighborhood Pharmacy Meds Admin by: Self Page 2

3 Drug Allergies/Adverse Effects: NKDA Family Medical History: Sister (71) DM Type 2 and heart problems ; Father died of stroke in his seventies; Mother died of colon cancer in her seventies. Social History Residence: lives at home w/ wife Smoking: Previously smoked 1PPD; quit 25 years ago Illicit Drugs: Never Occupation: Retired school teacher/coach EtOH: Drinks 1-2 beers or glasses of wine occasionally/socially Diet: Tries to eat healthy; does not add salt to food; wife cooks all his meals Education: college degree Family/Social Environment: Lives with wife; 3 grown children who live in the area; 2 grandchildren Objective Data (observations/vital signs/physical examination/labs) General: pleasant elderly male in NAD BP= 136/68 mmhg Pulse= 72 bpm regular Height = 5 11 Weight = 195 lbs BMI =27.2 kg/m 2 Laboratory Tests (measured this morning) FASTING Glucose = 110 mg/dl Na = 141 mg/dl K = 4.8 mg/dl Cl = 101 mg/dl CO3 = 24 mg/dl BUN = 13 mg/dl SCr = 1.1 mg/dl egfr > 60 ml/min/1.73m 2 Alb = 4.0 mg/dl AST = 22 ALT = 34 TSH = 2.96 Urinalysis: ph 7.05; Sp Gr 1.015; gluc (-), blood (-), epi (0-2), wbc (0-2), rbc (0-2), bact (none) DRE: smooth, rubbery prostate estimated size gm Post Void Residual: 100 ml (estimated via bladder scan) AUA-SI Score = 12 (0=not at all; 1=less than 1 in 5 times; 2=less than ½ of the time; 3= ½ of the time; 4=more than ½ of the time; 5=almost always; *=number per night) 1. Incomplete emptying: 1 2. Frequency: 0 3. Intermittency: 4 4. Urgency: 0 5. Weak stream: 3 6. Straining: 1 7. Nocturia*: 3 Severity of symptoms (total score): 0-7=mild; 8-19=moderate; 20-35=severe Page 3

4 Question #1 Which of the following medications could be contributing to BM s symptoms? a) Amlodipine b) Hydrochlorothiazide c) Losartan d) Levothyroxine Question #2 Based on BM s described symtptoms, AUS-SI score and his PVR, would you classify his LUTS as obstructive, irritative, or a combination of obstructive and irritative? a) Obstructive b) Irritative c) Combination of obstructive and irritative Question #3 The medication identified in Question #1 is discontinued. Six weeks later, the patient presents to clinic with similar complaints and his AUA-SI score has not changed substantially, as it is now His BP reading today is 138/72 mmhg. Which of the following would be the best option to consider for treating his BPH symptoms? a) Finasteride b) Dutasteride c) Terazosin d) Tamsulosin Question #4 What monitoring would be recommended for BM with regard to implementation of this new treatment to evaluate efficacy and safety? a) AUA-SI b) PVR c) Adverse Effects d) All the above Page 4

5 Question #5 Three months after beginning his new treatment, BM is scheduled to have cataract surgery. What would be recommended for him in this situation? a) BPH treatment should be discontinued for 1 month b) Cataract surgery should be cancelled c) Change treatment to a non-selective alpha blocker d) Ensure the ophthalmologist is aware of alpha blocker use Page 5

6 CASE #1 Part 2 Date: 7 years later Initials BM DOB/Age 79 yo Sex M Race/Ethnicity Caucasian Source Patient and medical records CC/HPI (including sx analysis for CC): The patient presents to his primary care physician for follow-up, two weeks after having been seen in the ER for an episode of acute urinary retention (AUR) requiring catheterization. This is the first episode of AUR that BM has experienced. He has experienced occasional episodes of urinary incontinence, but states that this occurs maybe once per month, if he has difficulty getting to the bathroom in time. Past Medical History (major illnesses and surgeries) From Medical Record HTN x 30+ years Hypothyroidism x 20+ years BPH (medically treated) s/p TIA x 2 (2011 and 2016) History of Falls (x 2, w/o injury) Cognitive impairment/dementia (MMSE Score = 22) Current Prescription/OTC Medications Start Date Drug Name/Strength/Regimen Indication 2 mo Acetaminophen PM daily HS Sleep 3 yrs Donepezil 10mg daily Cognitive impairment 4 yrs Tamsulosin 0.8 mg daily Stroke prevention 7 yrs Clopidogrel 75mg daily BPH 10 yrs Losartan 50mg daily HTN 11 yrs Hyrdrochlorothiazide 25mg daily HTN 12 yrs Levothyroxine 0.1mg daily Hypothyroidism 14 yrs Acetaminophen 500mg 1-2 tablets BID Osteoarthritis Objective Data (observations/vital signs/physical examination/labs) General: pleasant male in NAD; A&0 x 3 BP= 132/70 mmhg Pulse= 72, bpm, regular Height = 5 11 Weight = 183 lbs BMI =25.5 kg/m 2 Laboratory Tests (measured in ER, non-fasting) Glucose = 126 mg/dl Na = 141 mg/dl K = 4.4 mg/dl Cl = 100 mg/dl CO3 = 23 mg/dl BUN = 14 mg/dl SCr = 1.2 mg/dl egfr = 60 ml/min/1.73m 2 Urinalysis: ph 6.95; Sp Gr 1.018; gluc (-), blood (+), epi (0-2), wbc (5-10), rbc (5-10), bact (rare); culture (-) at 48 hours Transrectal ultrasound (ER) = estimated prostate size 45 gm Page 6

7 Post Void Residual: 150 ml (estimated via bladder scan today) AUA-SI Score: 21 (today) 1. Incomplete emptying: 3 2. Frequency: 1 3. Intermittency: 5 4. Urgency: 1 5. Weak stream: 4 8. Straining: 4 9. Nocturia*: 3 Question #6 What was the most likely cause of BM s recent AUR episode? a) BPH clinical progression b) Drug-induced effect c) Acute illness d) Impossible to determine Question #7 Which of the following recommendations would most likely reduce the risk of future BPH-related complications in BM? a) Initiate tolterodine b) Switch tamsulosin to terazosin c) Initiate finasteride d) Switch tamsulosin to alfuzosin Question #8 Which of the following would be important for educating BM? a) Risk of adverse effects b) Timeframe for expected improvement c) Avoid medications that can exacerbate symptoms d) All the above Page 7

8 Question #9 If BM was taking tamsulosin and he had complaints of bothersome symptoms with the following: AUA-SI = 14 (frequency=5; urgency=5; nocturia=4), PVR=45ml, prostate size 35ml, which treatment option would be most effective for treating his urinary symptoms in this scenario? a) Finasteride b) Dutasteride c) Tolterodine d) Doxazosin Page 8

9 CASE #2 Part 1 Initials BB American Pharmacists Association Annual Meeting 2016 March 2016 DOB/Age 55 Sex M Race/Ethnicity African American Source Patient and Medical Records CC/HPI (including sx analysis for CC): I m having problems with sexual function. Patient presents to his primary care physician for an annual wellness exam, but has also brought up his sexual function concerns. He has no other symptoms that are bothering him. His medication list was updated and he is taking a new supplement. He does not know the name of it, but he says it is not helping him. He does not really exercise much other than taking his dog for a walk once a week. He usually walks for 1 mile and it takes him about 30 minutes. He is a salesman and is either in the car traveling or meeting with clients. He eats at restaurants every day during the week for lunch, but eats at home for his other meals. He still smokes ½ ppd and has attempted to quit twice in the past few years. The last attempt, he quit cold turkey and was successful for 1 month. He is open to quitting. His physician ordered the following labs: metabolic panel, A1c, fasting lipids; the patient states he was fasting for over 12 hrs when the blood was drawn. Past Medical History (major illnesses and surgeries) From Medical Record Hypertension Dyslipidemia Osteoarthritis of knee Obesity Depression Current Prescription/OTC Medications Start Date Drug Name/Strength/Regimen Indication 1/2015 Naproxen 500 mg BID Osteoarthritis 2010 HCTZ 50 mg daily Hypertension 2010 Simvastatin 40mg daily Dyslipidemia 2010 Amlodipine 10 mg daily Hypertension 11/2015 Spironolactone 25 mg daily Hypertension 10/2015 Sertraline 50 mg daily Depression 1/2016 Virility supplement (patient does not know exact name) Erectile health Vaccinations: Influenza vaccine fall 2015; Tdap 2 years ago Pharmacy Used: Neighborhood Pharmacy Rx Payment: Commercial insurance ($0/$20/$50 copay) Meds Admin by: Self Drug Allergies/Adverse Effects: Sulfonamides, lisinopril (cough) Family Medical History: 1 sibling, with HTN and T2DM; father and mother still alive and in their 70s Social History Residence: lives at home with wife Occupation: salesman Page 9

10 Smoking: ½ ppd X 20 years EtOH: 1-2 beers on weekends and rarely during the week Illicit Drugs: Marijuana in the past (college years) Diet: His wife cooks most meals and he eats whatever she makes; struggles at work with snacking on salty foods and eats out most lunches Education: college graduate Family/Social Environment: Lives with wife; 2 grown children Sexual Health Inventory for Men Over the Past 6 Months: 1. How do you rate your confidence that you could get and keep an erection? 2. When you had erections with sexual stimulation, how often were your erections hard enough for penetration (entering your partner)? 3. During sexual intercourse, how often were you able to maintain your erection after you had penetrated (entered) your partner? 4. During sexual intercourse, how difficult was it to maintain your erection to completion of intercourse? 5. When you attempted sexual intercourse, how often was it satisfactory for you? NO SEXUAL ACTIVITY DID NOT ATTEMPT VERY LOW LOW MODERATE HIGH VERY HIGH ALMOST NEVER OR NEVER A FEW TIMES (MUCH LESS THAN HALF THE TIME) SOMETIMES (ABOUT HALF THE TIME) MOST TIMES (MUCH MORE THAN, HALF THE TIME) ALMOST ALWAYS OR ALWAYS INTERCOURSE DID NOT ATTEMPT ALMOST NEVER OR NEVER A FEW TIMES (MUCH LESS THAN HALF THE TIME) SOMETIMES (ABOUT HALF THE TIME) MOST TIMES (MUCH MORE THAN, HALF THE TIME) ALMOST ALWAYS OR ALWAYS INTERCOURSE DID NOT EXTREMELY DIFFICULT VERY DIFFICULT DIFFICULT SLIGHTLY DIFFICULT NOT DIFFICULT ATTEMPT INTERCOURSE ALMOST NEVER OR NEVER A FEW TIMES (MUCH LESS THAN HALF THE TIME) SOMETIMES (ABOUT HALF THE TIME) MOST TIMES (MUCH MORE THAN, HALF THE TIME) ALMOST ALWAYS OR ALWAYS Add the numbers corresponding to questions 1-5. TOTAL: 14 The Sexual Health Inventory for Men further classifies ED severity with the following breakpoints: 1-7 Severe ED 8-11 Moderate ED Mild to Moderate ED Mild ED Page 10

11 Objective Data (observations/vital signs/physical examination/labs) Blood Pressure: 145/77 mmhg Pulse: 80 Height: 72 inches Weight: 235 lbs BMI: 31.9 kg/m 2 Laboratory Tests (measured this morning) - FASTING A1c = 6.0% Na = 138 mg/dl K = 4.0 mg/dl Cl = 99 mg/dl CO2 = 24 mg/dl BUN = 12 mg/dl SCr = 1.0 mg/dl egfr = ml/min/1.73m 2 Alb = 4.2 mg/dl AST = 20 ALT = 17 Total Cholesterol = 167 mg/dl LDL = 98 mg/dl HDL = 48 mg/dl TG = 105 mg/dl Question #10 Which of the following medications may be contributing to BB s symptoms of erectile dysfunction (ED)? a) HCTZ b) Sertraline c) Spironolactone d) All of the above Question #11 Which of the following comorbidities could be contributing to BB s symptoms of ED? a) HTN b) Obesity c) Depression d) All of the above Question #12 Which of the following lifestyle factors is most likely contributing to BB s symptoms of ED? a) Smoking b) Alcohol intake c) Eating salty foods d) All of the above Page 11

12 Question #13 Which of the following additional screening tests would be the most important to discuss with BB at this time? a) PSA b) Serum testosterone c) Exercise ability/treadmill test d) Colorectal cancer screening test Question #14 Which of the following therapeutic plans would be most appropriate for BB s erectile and overall health? a) Add sildenafil b) Discontinue naproxen c) Reduce dose of sertraline d) Change spironolactone to losartan Page 12

13 e) CASE #2 Part 2 Date: 5 years later Initials BB DOB/Age 60 years Sex M Race/Ethnicity African American Source Patient and Medical Records CC/HPI (including sx analysis for CC): The patient presents to his primary care physician this morning for a follow-up ambulatory visit. His erectile dysfunction has been treated for the past several years with tadalafil as needed, and he really likes the flexibility of how long-acting it is, along with it is covered by his prescription plan. He sometimes gets back pain when he takes it, but he takes acetaminophen for that pain. However, he describes that he has less sexual desire than in the past and decreased morning erections. Four years ago, he made significant improvements in his diet and exercise and he lost 30 pounds. He swims for about 30 minutes almost daily, along with short walks with his dog, and weight lifting three times weekly. He rarely takes naproxen, but does take acetaminophen daily. He also quit smoking and has maintained that for the past 3 years. Recently, he was diagnosed with angina, but he has not had chest pain symptoms since the initial diagnosis, which was made in the Emergency Department. He also describes some hot flushes and loss of body hair. Past Medical History (major illnesses and surgeries) From Medical Record Hypertension Dyslipidemia Osteoarthritis of knee Overweight Depression Chronic stable angina Insomnia Current Prescription/OTC Medications Start Date Drug Name/Strength/Regimen Indication 5 yrs ago Naproxen 500 mg BID prn Osteoarthritis 10 yrs ago HCTZ 12.5 mg daily Hypertension Last month Atorvastatin 40mg daily Dyslipidemia 10 yrs ago Amlodipine 10 mg daily Hypertension 5 yrs ago Losartan 50 mg daily Hypertension 5 yrs ago Bupropion ER 300 mg daily Depression Within 1 yr Aspirin 81 mg daily Cardiovascular health 12 yrs ago Acetaminophen mg 4 times daily prn Osteoarthritis Last month Nitroglycerin 0.4 mg SL prn chest pain Chronic stable angina 2 yrs ago Zolpidem 5 mg daily Insomnia Page 13

14 SHIM test: 20 points Objective Data (observations/vital signs/physical examination/labs) Blood Pressure: 122/72 mmhg Pulse: 76 Height: 72 in Weight: 202 lbs BMI: 27.4 kg/m 2 Laboratory Tests (In Office) A1c = 5.5% Na = 139 mg/dl K = 4.6 mg/dl Cl = 99 mg/dl CO2 = 24 mg/dl BUN = 12 mg/dl SCr = 1.1 mg/dl egfr = 91.8 ml/min/1.73m 2 Hgb = 15.3 g/dl HCT = 47.9% PLT = /L PSA = 2.3 ng/ml AST = 24 ALT = 32 Total testosterone = 200 ng/dl Free testosterone = 6.0 ng/dl FSH = 22.0 miu/ml LH = 15.8 miu/ml Question #15 Which of the following medications is inappropriate for BB at this time? a) Zolpidem b) Tadalafil c) Naproxen d) Amlodipine Question #16 Based upon BB s laboratory work-up, new medical conditions, and new medications, which of the following treatments would be appropriate for his ED? a) Continue tadalafil and add testosterone replacement b) Continue tadalafil without testosterone replacement c) Discontinue tadalafil and add testosterone replacement d) Discontinue tadalafil without testosterone replacement Question #17 Which of the following laboratory measurements would be important to monitor for if BB elects to use testosterone replacement in the future? a) FSH b) LH c) Hemoglobin/hematocrit d) Evening testosterone concentrations Page 14

15 References : Answer Key: Q1 a Q2 a Q3 - d Q4 - d Q5 - d Q6 - b Q7 - c Q8 - d Q9 - c Q10 - d Q11 - d Q12 a Q13 c Q14 d Q15 b Q16 c Q17 c Page 15

Topic: Chronic Heart Failure Cases for Monday s March 21th lecture.

Topic: Chronic Heart Failure Cases for Monday s March 21th lecture. 1 Phar6122: CV section Date: 3/10/05 Topic: Chronic Heart Failure Cases for Monday s March 21th lecture. Directions: This handout includes three chronic heart failure cases of increasing difficulty. In

More information

Complete this CE activity online at ProCE.com/InsulinPart2

Complete this CE activity online at ProCE.com/InsulinPart2 Complete this CE activity online at ProCE.com/InsulinPart2 Case 1: A 67 year old male with T2DM History and Presentation John is a 67 year old retiree who has been visiting your pharmacy/clinic for over

More information

Case studies: LUTS. Case 1 history. Case 1 - questions. Case 1 - outcome. Case 2 - history. Case 1 learning point 14/07/2015 DR JON REES

Case studies: LUTS. Case 1 history. Case 1 - questions. Case 1 - outcome. Case 2 - history. Case 1 learning point 14/07/2015 DR JON REES Case 1 history Case studies: LUTS DR JON REES A 49 year old male comes to see you he has had gradual deterioration of his flow over the last few years- he saw a colleague of yours 6 weeks ago who recorded

More information

Benign Prostatic Hyperplasia (BPH):

Benign Prostatic Hyperplasia (BPH): Benign Prostatic Hyperplasia (BPH): Evidence Based Guidelines for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the pathophysiology and prevalence of BPH 2. Select the appropriate

More information

Case Studies in T2DM A Comprehensive Management Approach

Case Studies in T2DM A Comprehensive Management Approach Case Studies in T2DM A Comprehensive Management Approach John E. Anderson, MD The Frist Clinic Nashville, TN 43 yo Latina woman with 5 yrs T2DM. Originally diagnosed with PCOS and IGT by GYN at 32 yo.

More information

Application of the Diabetes Algorithm to a Patient

Application of the Diabetes Algorithm to a Patient Application of the Diabetes Algorithm to a Patient Apply knowledge gained from this activity to improve disease management and outcomes for patients with T2DM and obesity Note: The cases in this deck represent

More information

Management of LUTS. Simon Woodhams February 2012

Management of LUTS. Simon Woodhams February 2012 Management of LUTS Simon Woodhams February 2012 The management of lower urinary tract symptoms (LUTS) in men Implementing NICE guidance May 2010 NICE clinical guideline 97 Background Lower urinary tract

More information

Reason for referral: provide patient education on management of hypoglycemia and glucose monitor

Reason for referral: provide patient education on management of hypoglycemia and glucose monitor Meet Robin Sawyer (otherwise known as PT 1): Let s Create a Care Plan! Reason for referral: provide patient education on management of hypoglycemia and glucose monitor History of present illness: 40 45

More information

Patient is a 60 YO MALE seen in clinic for diabetes management follow-up. Allergies/ADEs: FLUNISOLIDE, PRIMIDONE, ALEVE CAPLET, CARBAMAZEPINE

Patient is a 60 YO MALE seen in clinic for diabetes management follow-up. Allergies/ADEs: FLUNISOLIDE, PRIMIDONE, ALEVE CAPLET, CARBAMAZEPINE Patient is a 60 YO MALE seen in clinic for diabetes management follow-up. Allergies/ADEs: FLUNISOLIDE, PRIMIDONE, ALEVE CAPLET, CARBAMAZEPINE Dx/Hx: uncontrolled DM and HTN Lifestyle: Patient usually sleeps

More information

Men s Health Concerns: Widely Experienced, Widely Misunderstood

Men s Health Concerns: Widely Experienced, Widely Misunderstood Men s Health Concerns: Widely Experienced, Widely Misunderstood Sunny Linnebur, Pharm.D., BCPS, FCCP, FASCP, CGP Associate Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical

More information

It Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia

It Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia It Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia Jacqueline LaManna, PhD, ANP BC, BC ADM, CDE Holly Divine, PharmD, BCACP, CGP, CDE, FAPhA Disclosures Dr. Jacqueline LaManna

More information

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES Risk Factors or Complications Glycemic Control Fasting & Capillary Plasma Glucose Anti-platelet

More information

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines Conflict of Interest Disclosure Updates for the Ambulatory Care Pharmacist: Dyslipidemia and CV Risk Assessment No conflicts of interest to disclose 2014 Updates to the Updates in Ambulatory Care Pharmacy

More information

Case Discussions: Treatment Strategies for High Risk Populations. Most Common Reasons for Referral to the Baylor Lipid Clinic

Case Discussions: Treatment Strategies for High Risk Populations. Most Common Reasons for Referral to the Baylor Lipid Clinic Case Discussions: Treatment Strategies for High Risk Populations Peter H. Jones MD, FNLA Associate Professor Methodist DeBakey Heart and Vascular Center Baylor College of Medicine Most Common Reasons for

More information

VS: BP 165/90, P 98, RR 18, T 37 C; waist circ 38 in, Wt 240 lbs (109 kg), Ht 5'8''

VS: BP 165/90, P 98, RR 18, T 37 C; waist circ 38 in, Wt 240 lbs (109 kg), Ht 5'8'' IMC Didactic Case-Diabetes Mellitus Chief Complaint "I was recently diagnosed with diabetes and would like to have my blood sugar tested. I think that my blood sugar is running low because I have the shakes

More information

Topic: Chronic Heart Failure Cases for Monday s March 21th lecture.

Topic: Chronic Heart Failure Cases for Monday s March 21th lecture. 1 Phar6122: CV section Date: 3/21/05 Topic: Chronic Heart Failure Cases for Monday s March 21th lecture. Directions: This handout includes three chronic heart failure cases of increasing difficulty. In

More information

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH INTRODUCTION (1) Part of male sexual reproductive organ Size

More information

APhA March 2016 Annual Meeting Obesity Cases

APhA March 2016 Annual Meeting Obesity Cases APhA March 2016 Annual Meeting Obesity Cases Case #1 Pam is a 47 yo obese Caucasian woman; grade school teacher with a history of HTN, HoTR, and depression who presents for her annual physical. CC: I m

More information

Board Review with The Chiefs. October 17, 2016 October 23, 2016

Board Review with The Chiefs. October 17, 2016 October 23, 2016 Board Review with The Chiefs October 17, 2016 October 23, 2016 Overview Registration Exam Details Test Day Details Study Resources Study Strategies Women s Health Men s Health What to Expect: Exam Registration

More information

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Disclosure No relevant

More information

A 45 year old African American man presents to the IMC with a chief complaint of my

A 45 year old African American man presents to the IMC with a chief complaint of my AN EVIDENCE BASED APPROACH TO HYPERTENSION AND HYPERLIPIDENIA: A CASE STUDY A 45 year old African American man presents to the IMC with a chief complaint of my pressure is high. Apparently he recently

More information

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP Introduction to Enlarged Prostate E. David Crawford, MD Professor of Surgery (Urology) and Radiation Oncology Head, Urologic Oncology E. David Crawford Endowed Chair in Urologic Oncology University of

More information

Victoria Sharp, MD, MBA, FAAFP. Clinical Professor of Urology and Family Medicine

Victoria Sharp, MD, MBA, FAAFP. Clinical Professor of Urology and Family Medicine Victoria Sharp, MD, MBA, FAAFP Clinical Professor of Urology and Family Medicine Victoria Sharp, MD, MBA, FAAFP Market Chief Medial Officer AmeriHealth Caritas Family of Companies Office phone: (515) 330-3740

More information

UROLOGY CENTER OF PALM BEACH, P.A.

UROLOGY CENTER OF PALM BEACH, P.A. UROLOGY CENTER OF PALM BEACH, P.A. Name Date Date of Birth Age Sex (circle one) M F Social Security # Marital Status (circle one) Married Divorced Single Widowed Separated Home Address City Zip Home Phone

More information

Medicare Wellness. Meggan Robinson, DO MAOFP Spring Update 4/23/16

Medicare Wellness. Meggan Robinson, DO MAOFP Spring Update 4/23/16 Medicare Wellness Meggan Robinson, DO MAOFP Spring Update 4/23/16 Objectives History of Medicare Wellness Exam Identify the goals of the Wellness exam Differentiate the different types of Wellness exams

More information

Placebo-Controlled Statin Trials Prevention Of CVD in Women"

Placebo-Controlled Statin Trials Prevention Of CVD in Women MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest

More information

Tools for Targeting High Risk Patients in Your Practice. Statement of Disclosure

Tools for Targeting High Risk Patients in Your Practice. Statement of Disclosure Tools for Targeting High Risk Patients in Your Practice Joseph Vande Griend, PharmD, BCPS, CGP Assistant Professor, University of Colorado Departments of Clinical Pharmacy and Family Medicine Skaggs School

More information

Oceanside Urology, LLC

Oceanside Urology, LLC Daniel J. Caruso, MD Kaveh Besharat, MD F. Andrew Celigoj, MD Consent for Treatment Patient s name: I,, agree and consent to participate in health care services offered and provided by Oceanside Urology,

More information

Case 1. Case 2. What do you think about reducing or discontinuing some of the above now that his LVEF has normalized?

Case 1. Case 2. What do you think about reducing or discontinuing some of the above now that his LVEF has normalized? Case 1 A primary care colleague inquires what to do with a patient (HFrEF in NSR) who has a digoxin level of 2.8ng/ml. Level was obtained at 10am, patient takes all medications at one time upon arising

More information

The Enlarged Prostate Symptoms, Diagnosis and Treatment

The Enlarged Prostate Symptoms, Diagnosis and Treatment The Enlarged Prostate Symptoms, Diagnosis and Treatment MAC00031-01 Rev G Financial support for this seminar has been provided by NeoTract, Inc., the manufacturer of the UroLift System. 1 Today s Agenda

More information

Male Lower Urinary Tract Symptoms: Management in primary care and beyond. Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon

Male Lower Urinary Tract Symptoms: Management in primary care and beyond. Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon Male Lower Urinary Tract Symptoms: Management in primary care and beyond Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon 1 LUTS Very common: 1/3 men over age of 50 have moderate to severe LUTS

More information

Testosterone Therapy in Men with Hypogonadism

Testosterone Therapy in Men with Hypogonadism Testosterone Therapy in Men with Hypogonadism (Endocrine Society 2018 Guideline) Ngwe Yin, MD Assistant Clinical Professor of Medicine, UCSF Fresno Medical Education Program Disclosures None Objective

More information

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Benign Prostatic Hyperplasia Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied,

More information

ABFM Diabetes SAM Part 4

ABFM Diabetes SAM Part 4 ABFM Diabetes SAM Part 4 37. A 55-year-old male with type 2 diabetes mellitus has a chronic history of reduced libido and erectile dysfunction. On examination you note hepatomegaly and mild testicular

More information

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI Hypertension, Hyperlipidemia and Obesity Mi-CCSI Objectives Review the prevalence of hypertension, hyperlipidemia and obesity Correlation of the 3 conditions Discuss why it is important to treat these

More information

Guidelines for Integrated Management of. Cardiovascular Diseases and Diabetes. in Clinics and Ri-hospitals

Guidelines for Integrated Management of. Cardiovascular Diseases and Diabetes. in Clinics and Ri-hospitals Guidelines for Integrated Management of Cardiovascular Diseases and Diabetes in Clinics and Ri-hospitals Ministry of Public Health DPR Korea January 2013 Rationale ncommunicable diseases such as cardiovascular

More information

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest

More information

Fall Risk Case Studies

Fall Risk Case Studies Case #1 Chief Complaint: I m just here for my normal visit, but I have some questions about falling. History of Present Illness: Mrs. Green is a 74-year-old female who is seeing her primary care provider

More information

CHALLENGING CASE PRESENTATION Steroid Induced Hyperglycemia

CHALLENGING CASE PRESENTATION Steroid Induced Hyperglycemia CHALLENGING CASE PRESENTATION Steroid Induced Hyperglycemia Javier Carrasco, MD, PhD Juan Ramón Jiménez Hospital University of Huelva, Spain Case Study: Medical and Social History A 60 years old female

More information

LUTS A plea for a holistic approach. HUBERT GALLAGHER, MCh; FRCSI, FRCSI(Urol) Head of Urology Beacon Hospital

LUTS A plea for a holistic approach. HUBERT GALLAGHER, MCh; FRCSI, FRCSI(Urol) Head of Urology Beacon Hospital LUTS A plea for a holistic approach. HUBERT GALLAGHER, MCh; FRCSI, FRCSI(Urol) Head of Urology Beacon Hospital LUTS- Classification Men LUTS can be divided into: Storage Voiding Frequency Nocturia Urgency

More information

Doctor s Instructions Patient: Mr Abdul Shareef Age: 40. Last Consultation Dr Mitchell 2 weeks ago

Doctor s Instructions Patient: Mr Abdul Shareef Age: 40. Last Consultation Dr Mitchell 2 weeks ago Doctor s Instructions Patient: Mr Abdul Shareef Age: 40 Last Consultation Dr Mitchell 2 weeks ago Telephone Triage: Patient just wants a routine blood test as FH of diabetes. Plan: Fasting blood test,

More information

All about the Prostate

All about the Prostate MEN S HEALTH Dr Nick Pendleton January 16 th 2018 All about the Prostate 1 What does it do? Functions of the Prostate 1. Secretes Prostatic Fluid slightly alkaline fluid, 30% of volume of seminal fluid,

More information

Incontinence: Risks, Causes and Care

Incontinence: Risks, Causes and Care Welcome To Incontinence: Risks, Causes and Care Presented by Kamal Masaki, MD Professor and Chair Department of Geriatric Medicine John A. Burns School of Medicine, UH Manoa September 5, 2018 10:00 11:00

More information

Date of Birth. Black/African American. What is your occupation? Retired? Yes No

Date of Birth. Black/African American. What is your occupation? Retired? Yes No Health Risk Assessment Today s Date: Name Date of Birth GENERAL INFORMATION What is your race? American Indian or Alaskan Native Native Hawaiian or Other Pacific Islander Asian, Chinese, Japanese, Korean

More information

Prostate surgery. What is the prostate? What is a TURP? Why is a TURP operation necessary? Deciding to have a TURP operation.

Prostate surgery. What is the prostate? What is a TURP? Why is a TURP operation necessary? Deciding to have a TURP operation. What is the prostate? The prostate is a gland about the size of a walnut that is only present in men. It is located just below the bladder and surrounds the urethra, the tube through which urine flows

More information

Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018

Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018 Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018 Points to Ponder ASCVD is the leading cause of morbidity

More information

Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano

Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano Dipartimento di Urologia Direttore Prof. Giorgio Guazzoni Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano alberto.saita@humanitas.it

More information

Prostate Health PHARMACIST VIEW

Prostate Health PHARMACIST VIEW Prostate Health PHARMACIST VIEW Prostate Definition Prostate is a gland made of fibromuscular tissue. It is about 4 cm and surrounds the neck of the bladder and the urethra. It produces seminal fluid.

More information

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing Hypertension and Hyperlipidemia University of Illinois at Chicago College of Nursing 1 Learning Objectives 1. Provide a basic level of knowledge regarding hypertension and hyperlipidemia and care coordinators/

More information

Benign Prostatic Hyperplasia. Management of Benign Prostatic Hyperplasia. Goals of Therapy

Benign Prostatic Hyperplasia. Management of Benign Prostatic Hyperplasia. Goals of Therapy Benign Prostatic Hyperplasia Management of Benign Prostatic Hyperplasia Goals of Therapy Improve or abolish lower urinary tract symptoms (LUTS) Prevent or delay clinical progression of benign prostatic

More information

Hypertension in the very old. Objectives: Clinical Perspective

Hypertension in the very old. Objectives: Clinical Perspective Harvard Medical School Hypertension in the very old Ihab Hajjar, MD, MS, AGSF Associate Director, CV Research Lab Assistant Professor of Medicine, Harvard Medical School Objectives: Describe the clinical

More information

Appendix A: Sample Patient Profiles and Prescriptions

Appendix A: Sample Patient Profiles and Prescriptions Appendix A: Sample Patient Profiles and Prescriptions (For Pharmacist Use) Sample Patient Profile 1 Name Mike Monroe Date of Birth 01/01/1957 Address 555 Happy Lane Phone 123-456-7890 Tucson, AZ 85704

More information

Cialis. Cialis (tadalafil) Description

Cialis. Cialis (tadalafil) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.06.02 Subject: Cialis Page: 1 of 5 Last Review Date: September 18, 2015 Cialis Description Cialis (tadalafil)

More information

Prostate Disease. Chad Baxter, MD

Prostate Disease. Chad Baxter, MD Prostate Disease Chad Baxter, MD Managing BPH and LUTS Chad Baxter, MD Department of Urology cbaxter@mednet.ucla.edu 33 nd Annual UCLA Intensive Course in Geriatric Medicine & Board Review Prevalence of

More information

10/9/2015. Dana A. Brown, Pharm.D., BCPS Assistant Dean for Academics, Associate Professor of Pharmacy Practice Palm Beach Atlantic University

10/9/2015. Dana A. Brown, Pharm.D., BCPS Assistant Dean for Academics, Associate Professor of Pharmacy Practice Palm Beach Atlantic University Dana A. Brown, Pharm.D., BCPS Assistant Dean for Academics, Associate Professor of Pharmacy Practice Palm Beach Atlantic University 1. Explain the pathophysiology of benign prostatic hyperplasia (BPH),

More information

PCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS

PCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS PCOS Awareness Symposium Atlanta September 24 th, 2016 Preventing Diabetes & Cardiovascular Disease in PCOS Katherine Sherif, MD Professor & Vice Chair, Department of Medicine Director, Jefferson Women

More information

The Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon

The Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon Prostate case study Presented by Mr Alan Thompson Consultant Urological Surgeon 2 Part one Initial presentation A 62 year old male solicitor attends your GP surgery. He has rarely seen you over the last

More information

Literature Scan: Drugs for BPH

Literature Scan: Drugs for BPH Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Lipid Management: The Next Level How Will the New ACC/AHA Guidelines Change My Practice

Lipid Management: The Next Level How Will the New ACC/AHA Guidelines Change My Practice Lipid Management: The Next Level How Will the New ACC/AHA Guidelines Change My Practice Vera Bittner, MD, MSPH Professor of Medicine Section Head, Preventive Cardiology Medical Director, Cardiac Rehabilitation

More information

Treat-to-Target Tools

Treat-to-Target Tools TEAMcare Care Manager Primary Care Provider Treat to Target Discussion Tool for Treatment Enhancement Activation and Motivation (TEAM) Depression, Diabetes and Coronary Heart Disease (CHD) Intervention

More information

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Diagnostic approach to LUTS in men Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Classification of LUTS Storage symptoms Voiding symptoms Post micturition

More information

Elements for a Public Summary

Elements for a Public Summary VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Benign prostatic hyperplasia (BPH), also called benign prostatic hypertrophy or benign prostatic obstruction, is a condition in

More information

Medical History Form

Medical History Form Medical History Form Name: ; Birth date: / / ; Date: / / Person filling out form: ; Relationship: Thank you for taking the time to fill out this valuable information. This allows us to provide the best

More information

2017 SNPhA/Kroger Clinical Skills National Competition: Las Vegas, NV: DIVISION II

2017 SNPhA/Kroger Clinical Skills National Competition: Las Vegas, NV: DIVISION II 1 2017 SNPhA/Kroger Clinical Skills National Competition: Las Vegas, NV: DIVISION II Name: Kamran Johns Date: 7/28/17 CC: I think I m dehydrated, how much water do I need to drink each day? HPI: KJ is

More information

Address: City: State: Zip: Home #: Work #: Cell #: Emergency Contact (Relationship) and Number: Primary Care P cian:

Address:   City: State: Zip: Home #: Work #: Cell #: Emergency Contact (Relationship) and Number: Primary Care P cian: Office of Dr. Ash K. Tewari, MD DOB: Age: Email: City: State: Zip: Home #: Work #: Cell #: Emergency Contact (Relationship) and Number: Referring MD: Primary Care Pcian: Check if PMD is the Referring MD

More information

PATIENT INFORMATION 2017 NeoTract, Inc. All rights reserved. Printed in the USA. MAC Rev A

PATIENT INFORMATION 2017 NeoTract, Inc. All rights reserved. Printed in the USA. MAC Rev A PATIENT INFORMATION OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1 BPH affects more than 500 million men worldwide, with many men suffering from symptoms of enlarged prostate. 1 You no longer have

More information

Alcohol and substance misuse: objectives

Alcohol and substance misuse: objectives AAIM 2012 WS J: Alcohol & substance misuse Robert Coates MD Marianne Cumming MD Joseph Huguenard MD Alcohol and substance misuse: objectives Detection and mortality risk assessment of alcohol and substance

More information

Case Study #4: Hypertension and Cardiovascular Disease

Case Study #4: Hypertension and Cardiovascular Disease Helen Jang Tara Hooley John K Rhee Case Study #4: Hypertension and Cardiovascular Disease 7. What risk factors does Mrs. Sanders currently have? The risk factors that Mrs. Sanders has are high blood pressure

More information

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient

More information

H6D-MC-LVHR Clinical Study Report Synopsis Page LVHR Synopsis (LY450190)

H6D-MC-LVHR Clinical Study Report Synopsis Page LVHR Synopsis (LY450190) H6D-MC-LVHR Clinical Study Report Synopsis Page 1 2. LVHR Synopsis H6D-MC-LVHR Clinical Study Report Synopsis Page 2 Clinical Study Report Synopsis: Study H6D-MC-LVHR Title of Study: A Randomized, Double-Blind,

More information

Pharmacology Challenges: Managing Statin Myalgia

Pharmacology Challenges: Managing Statin Myalgia Clinical Case: RM is a 50 year-old African American woman with a past medical history of type diabetes, dyslipidemia, hypertension and peripheral arterial disease. She had been prescribed simvastatin 80

More information

VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS

VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS DR. FRANCIS LEE Voiding dysfunction Storage Emptying Common voiding dysfunction in elderly male Emptying BPH Storage Incontinence Overactive bladder Post-prostatectomy

More information

Dr. Robert J. Anderson Squires and Stags February 3, 2017

Dr. Robert J. Anderson Squires and Stags February 3, 2017 Dr. Robert J. Anderson Squires and Stags February 3, 2017 Incidence: 10% per year starting at age 50 Prostate gland pinches the urethra=urinary Sx Frequency Urgency Hesitancy Weak Stream Incomplete Bladder

More information

Cialis. Cialis (tadalafil) Description

Cialis. Cialis (tadalafil) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.22 Subject: Cialis Page: 1 of 5 Last Review Date: September 15, 2017 Cialis Description Cialis (tadalafil)

More information

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms Storage Symptoms Frequency, urgency, incontinence, Nocturia Voiding Symptoms Hesitancy, poor flow, intermittency,

More information

Stelios Mantis, MD DuPage Medical Group Pediatric Endocrinology

Stelios Mantis, MD DuPage Medical Group Pediatric Endocrinology Stelios Mantis, MD DuPage Medical Group Pediatric Endocrinology 4 11 13 Initial Presentation Pt initially presented to pediatrician for school physical in fall 2012. Pt was found to be overweight (BMI:

More information

What is Benign Prostatic Hyperplasia (BPH)?

What is Benign Prostatic Hyperplasia (BPH)? What is Benign Prostatic Hyperplasia (BPH)? Benign prostatic hyperplasia (BPH) is an enlarged prostate. The prostate goes through two main growth periods as a man ages. The first occurs early in puberty,

More information

Learning Objectives. Patient Case

Learning Objectives. Patient Case Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS Professor and Vice Chair, Department of Clinical Pharmacy University of Colorado Anschutz Medical Campus Learning Objectives Identify the 4 patient populations

More information

Difficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair

Difficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair Difficult-to-Control & Resistant Hypertension Anthony Viera, MD, MPH, FAHA Professor and Chair Objectives Define resistant hypertension Discuss evaluation strategy for patient with HTN that appears difficult

More information

Hypertension Update Clinical Controversies Regarding Age and Race

Hypertension Update Clinical Controversies Regarding Age and Race Hypertension Update Clinical Controversies Regarding Age and Race Allison Helmer, PharmD, BCACP Assistant Clinical Professor Auburn University Harrison School of Pharmacy July 22, 2017 DISCLOSURE/CONFLICT

More information

Endocrinology TeleECHO Clinic Case Presentation Form

Endocrinology TeleECHO Clinic Case Presentation Form Endocrinology TeleECHO Clinic Case Presentation Form Complete ALL ITEMS on this form and fax to 503.228.4801 PLEASE NOTE that case consultations do not create or otherwise establish a provider-patient

More information

Preventive Services Explained

Preventive Services Explained Preventive Services Explained Medicare covers many preventive care services without charge. Most of these services have been recommended by the U.S. Preventive Services Task Force. However, which beneficiaries

More information

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Management of Lipid Disorders and Hypertension Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine

More information

Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia (BPH) Benign Prostatic Hyperplasia (BPH) Definition Prostate gland enlargement is a common condition as men get older. Also called benign prostatic hyperplasia (BPH), prostate gland enlargement can cause bothersome

More information

Y0028_2726_0 File&Use Bladder Control Does Matter

Y0028_2726_0 File&Use Bladder Control Does Matter Y0028_2726_0 File&Use 04092012 Bladder Control Does Matter If you suffer from urinary incontinence, you re not alone Don t be afraid to raise your hand if you ve been struggling with the embarrassment

More information

PATIENT REGISTRATION PERSON TO NOTIFY IN CASE OF EMERGENCY. Name: Relationship: Phone:

PATIENT REGISTRATION PERSON TO NOTIFY IN CASE OF EMERGENCY. Name: Relationship: Phone: PATIENT REGISTRATION Patient's Name (Last, First, MI): Date of Birth: Age: Sex: M / F Social Security Number: Address: Apt. # City: State: Zip: Home Number: Mobile Number: Work Number: Employment Status:

More information

Jared Moore, MD, FACP

Jared Moore, MD, FACP Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner

More information

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series Our speaker today is: Susan Vos, BSN, RN, CCM Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series We will be starting shortly A few housekeeping items: We will be

More information

Updates in Cardiovascular Recommendations for Diabetic Patients

Updates in Cardiovascular Recommendations for Diabetic Patients Updates in Cardiovascular Recommendations for Diabetic Patients Chris Tawwater, Pharm.D., BCPS Clinical Pharmacist, Abilene Regional Medical Center Assistant Professor, Adult Medicine Division Pharmacotherapy

More information

NATIONAL ASSOCIATION FOR CONTINUING EDUCATION. Experts on Call: Current Issues in the Management of Hypogonadism:

NATIONAL ASSOCIATION FOR CONTINUING EDUCATION. Experts on Call: Current Issues in the Management of Hypogonadism: NATIONAL ASSOCIATION FOR CONTINUING EDUCATION Experts on Call: Current Issues in the Management of Hypogonadism: 2013-2014 Final Outcome Report for Three Live Online Webinars Report Date: 03/10/2014 Copyright

More information

PATIENT REGISTRATION PERSON TO NOTIFY IN CASE OF EMERGENCY. Name: Relationship: Phone:

PATIENT REGISTRATION PERSON TO NOTIFY IN CASE OF EMERGENCY. Name: Relationship: Phone: PATIENT REGISTRATION Patient's Name (Last, First, MI): Date Date of Birth: Age: Sex: M / F Social Security Number: Address: Apt. # City: State: Zip: Home Number: Mobile Number: Work Number: PERSON TO NOTIFY

More information

Medical History. Instructions. My telephone number is: 1 Tools Medical History

Medical History. Instructions. My telephone number is: 1 Tools Medical History Medical History Instructions To do the best possible job with your heart failure, the doctor needs details about your history, including current and past medical problems, medications, health habits, and

More information

New Patient Paperwork

New Patient Paperwork Name (Last, First, M.I.): M F Email Address: Primary Phone: Race: Today's Date: DOB: Alternate Emergency Phone: Contact: American Indian/Alaska Native Asian African American Caucasian Nat Hawaiian/Pacific

More information

Andrea Berez, MS, RDN Registered Dietitian Nutritionist 6 Auer Court, Suite D, East Brunswick NJ

Andrea Berez, MS, RDN Registered Dietitian Nutritionist 6 Auer Court, Suite D, East Brunswick NJ Background Information Andrea Berez, MS, RDN Registered Dietitian Nutritionist 6 Auer Court, Suite D, East Brunswick NJ 08816. aberezrd@njpedsrd.com Adult Patient Nutrition Assessment/Diet History Form

More information

PRE-VISIT QUESTIONNAIRE FOR NEW PATIENTS

PRE-VISIT QUESTIONNAIRE FOR NEW PATIENTS UF Health Senior Care PO Box 100383 Gainesville, FL 32608 352-265-0615 Fax 352-294-5803 PRE-VISIT QUESTIONNAIRE FOR NEW PATIENTS Please complete this questionnaire at home and bring it with you to the

More information

Single Married Divorced Widowed Male Female

Single Married Divorced Widowed Male Female Annual Physical Form General Information Name Birth Date Phone Email Address Street Address City State Zip Marital Status Gender Single Married Divorced Widowed Male Female Employment Information Position

More information

MODULE 3: BENIGN PROSTATIC HYPERTROPHY

MODULE 3: BENIGN PROSTATIC HYPERTROPHY MODULE 3: BENIGN PROSTATIC HYPERTROPHY KEYWORDS: Prostatic hypertrophy, prostatic hyperplasia, PSA, voiding dysfunction, lower urinary tract symptoms (LUTS) At the end of this clerkship, the medical student

More information